Epithelial mesenchymal transition traits in human breast cancer cell lines

被引:349
作者
Blick, T. [1 ]
Widodo, E. [2 ,3 ]
Hugo, H. [4 ]
Waltham, M. [1 ]
Lenburg, M. E. [5 ,6 ]
Neve, R. M. [6 ]
Thompson, E. W. [1 ,2 ]
机构
[1] St Vincents Inst, VBCRC Invas & Metastasis Unit, Fitzroy, Vic 3065, Australia
[2] Univ Melbourne, St Vincent Hosp, Dept Surg, Fitzroy, VIC 3065, Australia
[3] Brawijaya Univ, Fac Med, E Java 65141, Indonesia
[4] Royal Childrens Hosp, Murdoch Childrens Res Inst, Embryol Lab, Parkville, VIC 3052, Australia
[5] Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02118 USA
[6] Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94270 USA
关键词
EMT; basal; luminal; mesenchymal; breast cancer; breast cancer stem cells;
D O I
10.1007/s10585-008-9170-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Epithelial mesenchymal transition (EMT) has long been associated with breast cancer cell invasiveness and evidence of EMT processes in clinical samples is growing rapidly. Genome-wide transcriptional profiling of increasingly larger numbers of human breast cancer (HBC) cell lines have confirmed the existence of a subgroup of cell lines (termed Basal B/Mesenchymal) with enhanced invasive properties and a predominantly mesenchymal gene expression signature, distinct from subgroups with predominantly luminal (termed Luminal) or mixed basal/luminal (termed Basal A) features (Neve et al Cancer Cell 2006). Studies providing molecular and cellular analyses of EMT features in these cell lines are summarised, and the expression levels of EMT-associated factors in these cell lines are analysed. Recent clinical studies supporting the presence of EMT-like changes in vivo are summarised. Human breast cancer cell lines with mesenchymal properties continue to hold out the promise of directing us towards key mechanisms at play in the metastatic dissemination of breast cancer.
引用
收藏
页码:629 / 642
页数:14
相关论文
共 99 条
[21]
Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-κB signaling as characteristics of a high-risk head and neck squamous cell carcinoma [J].
Chung, Christine H. ;
Parker, Joe S. ;
Ely, Kim ;
Carter, Jesse ;
Yi, Yajun ;
Murphy, Barbara A. ;
Ang, K. Man ;
El-Naggar, Adel K. ;
Zanation, Adam M. ;
Cmelak, Anthony J. ;
Levy, Shawn ;
Slebos, Robbert J. ;
Yarbrough, Wendell G. .
CANCER RESEARCH, 2006, 66 (16) :8210-8218
[22]
Roles of the transcription factors snail and slug during mammary morphogenesis and breast carcinoma progression [J].
Côme, C ;
Arnoux, V ;
Bibeau, F ;
Savagner, P .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2004, 9 (02) :183-193
[23]
Snail and slug play distinct roles during breast carcinoma progression [J].
Come, Christophe ;
Magnino, Fabrice ;
Bibeau, Frederic ;
Barbara, Pascal De Santa ;
Becker, Karl Friedrich ;
Theillet, Charles ;
Savagner, Pierre .
CLINICAL CANCER RESEARCH, 2006, 12 (18) :5395-5402
[24]
The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion [J].
Comijn, J ;
Berx, G ;
Vermassen, P ;
Verschueren, K ;
van Grunsven, L ;
Bruyneel, E ;
Mareel, M ;
Huylebroeck, D ;
van Roy, F .
MOLECULAR CELL, 2001, 7 (06) :1267-1278
[25]
Duband JL, 1995, ACTA ANAT, V154, P63
[26]
A gene expression signature associated with metastatic cells in effusions of breast carcinoma patients [J].
Dupont, Virginie N. ;
Gentien, David ;
Oberkampf, Marine ;
De Rycke, Yann ;
Blin, Nathalie .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (05) :1036-1046
[27]
Saethre-Chotzen mutations cause TWIST protein degradation or impaired nuclear location [J].
El Ghouzzi, V ;
Legeai-Mallet, L ;
Aresta, S ;
Benoist, C ;
Munnich, A ;
de Gunzburg, J ;
Bonaventure, J .
HUMAN MOLECULAR GENETICS, 2000, 9 (05) :813-819
[28]
Snail, slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma [J].
Elloul, S ;
Elstrand, MB ;
Nesland, JM ;
Tropé, CG ;
Kvalheim, G ;
Goldberg, I ;
Reich, R ;
Davidson, B .
CANCER, 2005, 103 (08) :1631-1643
[29]
Repression of Na,K-ATPase β1-subunit by the transcription factor snail in carcinoma [J].
Espineda, CE ;
Chang, JH ;
Twiss, J ;
Rajasekaran, SA ;
Rajasekaran, AK .
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (03) :1364-1373
[30]
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/"triple-negative'' breast cancer cell lines growing in vitro [J].
Finn, Richard S. ;
Dering, Judy ;
Ginther, Charles ;
Wilson, Cindy A. ;
Glaspy, Padraic ;
Tchekmedyian, Nishan ;
Slamon, Dennis J. .
BREAST CANCER RESEARCH AND TREATMENT, 2007, 105 (03) :319-326